Cervical Cancer Treatment in India: Your Complete Guide (2026)

Cervical cancer kills approximately 67,000 Indian women annually, making it the second most common cancer among Indian women after breast cancer. However, unlike many cancers, cervical cancer is largely preventable. It’s caused by persistent infection with high-risk strains of human papillomavirus (HPV), particularly HPV-16 and HPV-18. The HPV vaccine prevents these infections before they occur, reducing cervical cancer risk by 90%.

India has approved HPV vaccines for girls aged 9-45 years. The government has introduced HPV vaccination in some school programs, though coverage remains incomplete. Regular cervical screening (Pap smear or HPV testing) can detect precancerous changes before they become cancer, allowing for simple treatment. For women already diagnosed with cervical cancer, treatment options are well-established and highly effective when started early.

Cervical Cancer in India: The Prevention Opportunity

Cervical cancer kills approximately 67,000 Indian women annually, making it the second most common cancer among Indian women after breast cancer. However, unlike many cancers, cervical cancer is largely preventable. It’s caused by persistent infection with high-risk strains of human papillomavirus (HPV), particularly HPV-16 and HPV-18. The HPV vaccine prevents these infections before they occur, reducing cervical cancer risk by 90%.

India has approved HPV vaccines for girls aged 9-45 years. The government has introduced HPV vaccination in some school programs, though coverage remains incomplete. Regular cervical screening (Pap smear or HPV testing) can detect precancerous changes before they become cancer, allowing for simple treatment. For women already diagnosed with cervical cancer, treatment options are well-established and highly effective when started early.

HPV Vaccination: Your Best Prevention Tool

HPV vaccination is the most effective cervical cancer prevention strategy. The vaccines protect against the high-risk strains HPV-16 and HPV-18, which cause 70% of cervical cancers. They also protect against low-risk strains causing genital warts. The vaccine is given as a series of injections (2-3 doses depending on age and vaccine type) over 6-12 months.

Vaccination is most effective before sexual activity begins, typically ages 9-14. However, vaccines are approved and effective up to age 45. If you haven’t been vaccinated or are unsure of your vaccination status, discuss it with your gynecologist. The vaccine costs ₹5,000 to ₹15,000 per dose at private clinics. Government programs sometimes offer it free or subsidized. Getting vaccinated now prevents cervical cancer from developing in the future.

Cervical Screening: Early Detection Saves Lives

Regular cervical screening detects precancerous changes (dysplasia) before they become cancer. The two main screening methods are the Pap smear (conventional or liquid-based) and HPV testing. Pap smears detect abnormal cells; HPV testing detects the virus causing abnormalities. Many experts recommend HPV testing as more sensitive. Screening should begin at age 21 and continue until age 65, typically every 3-5 years depending on previous results.

Screening is quick, painless, and takes 2-3 minutes in your gynecologist’s office. A Pap smear costs ₹300-₹1,000. HPV testing costs ₹1,500-₹4,000. If screening shows abnormalities, your doctor recommends follow-up testing or treatment. Finding precancerous changes allows simple office procedures to remove them before cancer develops. Regular screening reduces cervical cancer mortality by up to 80%.

LEEP: Treatment for Precancerous Changes

Loop Electrosurgical Excision Procedure (LEEP) is an office procedure removing precancerous or cancerous tissue from the cervix. A thin wire loop carrying electrical current removes the abnormal area while simultaneously cauterizing the edges to minimize bleeding. The removed tissue is sent to pathology to confirm the diagnosis and ensure clean margins.

LEEP takes 10-15 minutes and causes minimal pain, usually requiring just local anesthesia. Recovery is quick, though you may have light spotting for 1-2 weeks. Success rate for removing precancerous lesions is 90-95%, with low recurrence rates. Cost ranges from ₹10,000 to ₹30,000 depending on the facility. For many women with precancerous changes, LEEP is curative and prevents cancer from developing.

Surgical Treatment for Early-Stage Cervical Cancer

For stage 1 cervical cancer confined to the cervix, surgery is often the primary treatment. A radical hysterectomy removes the uterus, cervix, and surrounding tissue. Some doctors perform a trachelectomy (preserving the uterus) in younger women wanting to preserve fertility, though this requires careful patient selection. These surgeries are often done with minimally invasive techniques (laparoscopic or robotic), resulting in smaller incisions, less pain, and faster recovery.

Hospital stay is typically 1-3 days. Full recovery takes 4-6 weeks. Five-year survival rates for stage 1 cervical cancer treated with surgery are 85-95%, with even better rates for stage 1A disease. If final pathology shows high-risk features, chemotherapy and radiation may be added after surgery. Surgical costs range from ₹2,00,000 to ₹6,00,000 depending on the approach and facility.

Chemotherapy and Radiation for Locally Advanced Disease

For stage 2B or higher cervical cancer, concurrent chemotherapy and radiation (chemoradiation) is the standard treatment. Chemotherapy drugs like cisplatin are given weekly during radiation therapy. Radiation includes both external beam (4-6 weeks of daily outpatient treatments) and internal radiation (brachytherapy, typically 4-5 applications).

This combined approach improves survival compared to radiation alone. Five-year survival for stage 2B is approximately 60-70%, and for stage 3 is 40-50%. The treatment is intensive and causes side effects like fatigue, nausea, and diarrhea, but these are manageable. After completing chemoradiation, most patients are monitored with regular follow-up imaging and exams. Treatment cost typically ranges from ₹4,00,000 to ₹10,00,000.

Advanced Disease: Palliative and Targeted Approaches

For metastatic cervical cancer (stage 4), chemotherapy is the primary treatment, sometimes combined with targeted therapy or immunotherapy. Bevacizumab, a drug targeting blood vessel formation, has shown benefit when added to chemotherapy. Immunotherapy drugs like pembrolizumab and nivolumab are emerging as promising options, particularly for PD-L1 positive tumors.

While stage 4 disease is incurable, treatment focuses on extending life and maintaining quality. Some patients achieve long-term remissions with ongoing therapy. Clinical trials offer access to newer treatments. Support from oncologists, gynecologists, and palliative care teams helps manage symptoms and side effects. Patient involvement in treatment decisions is important for balancing survival benefits with quality of life.

Post-Treatment Follow-up and Survivorship

After cervical cancer treatment, follow-up is essential to detect any recurrence early. Typical follow-up includes pelvic exams every 3-4 months for the first 2 years, then every 6 months for 3 years, then annually. Imaging (CT or MRI) is obtained if symptoms suggest recurrence. You can resume normal activities including sexual intercourse after healing, though some women report changed sensation or discomfort initially.

Fertility preservation should be discussed before treatment if you desire future pregnancies. Some women experience early menopause from radiation affecting ovaries, requiring hormone therapy discussion. Support groups and counseling help process treatment experiences. Most cervical cancer survivors live long, fulfilling lives after treatment, especially if caught early.